3 June 2021 - The U.S. FDA continues to facilitate the development and availability of innovative medical products, such as regenerative medicine therapies, that have the potential to treat or even cure diseases or conditions for which few effective treatment options exist. 

For example, the agency has recently licensed its first product that received regenerative medicine advanced therapy designation, underscoring our ongoing commitment to work with sponsors and manufacturers to bring these products to market.

Read FDA Voices